VEGFA and glioblastoma: The primary driver of angiogenesis in GBM is VEGF-A, which is secreted by tumor cells and binds to receptor VEGFR-2 on the endothelial cell surface, resulting in the activation of PI3K–Akt and MAP kinase pathways that promote endothelial cell proliferation and survival.